Define the operating boundary
A useful definition names the triggering event, required inputs, governing source, accountable owner, decision or action, exception path, evidence retained, and downstream handoff. Buyers should adapt those elements to their own population, jurisdictions, policies, systems, and control model before writing requirements.
The most important distinction is between a label and an operational capability. A provider may document bulk data access and export while depending on customer-supplied policy, licensed content, third-party data, integration partners, manual review, or services. The demonstration should expose those dependencies rather than hiding them behind a completed interface.
What a demonstration should prove
- Begin with representative source records and a named policy, standard, or controlled rule.
- Show the normal path, an ambiguous case, missing data, an exception, an override, and a material source change.
- Identify who can change rules, who can approve or reject, and how accountability is preserved.
- Trace every output back to inputs, versions, timestamps, user actions, and governing evidence.
- Export the resulting record and reconcile it with downstream systems and retained obligations.
Authority and operating context
FHIR R4 4.0.1
FHIR R4 defines resources, RESTful interactions, data types, terminology bindings, conformance artifacts, security considerations, and exchange patterns. It includes the first normative FHIR content and remains the base for major U.S. implementation guides. Buyers must distinguish base R4 support from support for a named profile or implementation guide. FHIR R4 does not establish production connectivity, semantic quality, authorization design, or conformity for a particular product.
US Core 9.0.0
US Core defines U.S. FHIR profiles, interactions, search expectations, and guidance for exchanging common clinical data. Version 9.0.0 remains based on FHIR R4 and incorporates current USCDI-oriented development. US Core version support is more decision-useful than a generic FHIR statement. Current publication, regulatory adoption, and voluntary SVAP availability must be recorded separately.
HTI-1 Final Rule
HTI-1 updates the ONC Health IT Certification Program, adopts USCDI v3 as the baseline from January 1, 2026, revises information-blocking provisions, adds algorithm-transparency requirements, and creates interoperability-focused reporting metrics. HTI-1 connects standards versions to certification and reporting obligations. Product roadmaps must distinguish the adopted baseline from newer voluntarily advanced specifications.
CMS-0057-F
CMS-0057-F expands Patient Access API content and requires Provider Access, Payer-to-Payer, and Prior Authorization APIs for impacted payers, with associated privacy, opt-in or opt-out, metrics, and operational provisions. The rule makes versioned FHIR implementation, bulk data, member permission, endpoint discovery, data lineage, and production operations central payer interoperability requirements.
Bulk Data Access 3.0.0
The Bulk Data Access guide defines asynchronous export patterns for large FHIR datasets, including system-, patient-, and group-level workflows and associated authorization considerations. Bulk export adds job orchestration, file security, filtering, deletion, monitoring, performance, and downstream stewardship requirements that are not answered by a synchronous FHIR API demo.
PDex 2.1.0
PDex profiles FHIR-based exchange of clinical, claims, encounter, and prior-authorization information among payers, patients, and providers and introduces bulk APIs for provider and payer-to-payer access. PDex is central to current payer data-exchange architecture, but buyers must track its US Core dependencies, API role, bulk behavior, member permission, and relationship to separate CARIN and Da Vinci guides.
Operating domains
Standards version and conformance control
Risk that organizations treat a standard as a timeless feature, combine incompatible versions or profiles, misstate certification or conformance, and release interfaces without reproducible evidence for the exact artifacts in use.
Operational reliability and observability
Risk that interfaces and networks appear implemented but fail silently, degrade, duplicate, delay, or lose data because monitoring, ownership, replay, escalation, maintenance, and service evidence are incomplete.
Information access, blocking, and workflow use
Risk that organizations cannot deliver electronic health information in an authorized, timely, usable manner—or mistake technical delivery for satisfaction of access, exchange, use, clinical, or operational responsibilities.
Evidence and comparison limits
Official provider documentation can establish product positioning. Provider confirmation can clarify package or availability. Independent observation requires a disclosed scenario, environment, date, inputs, and reproducible result. None of those sources alone establishes buyer-specific legal, clinical, regulatory, quality, or operational fitness.
Buyer questions
- What exact outcome and evidence should bulk data access and export produce?
- Which source, version, and customer facts govern the workflow?
- Which decisions remain human and who is accountable for them?
- What is native, configured, integrated, service-delivered, or planned?
- How does a changed source affect open and historical records?